Stay updated with breaking news from About Zai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Zai Lab Announces the Appointment of Josh Smiley as Chief Operating Officer SHANGHAI, SAN FRANCISCO, and CAMBRIDGE, Mass. March 15, 2022 -Zai Lab Limited , a... | March 15, 2022
Zai Lab Limited , a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that it has appointed Scott Morrison to its Board of Directors. Mr. Morrison will... | October 18, 2021
[December 28, 2020] Zai Lab Announces Inclusion of ZEJULA® (Niraparib) in China's National Reimbursement Drug List SHANGHAI and SAN FRANCISCO, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that ZEJULA® has been included in the updated National Reimbursement Drug List (NRDL) released by Chinaâs National Healthcare Security Administration (NHSA). ZEJULA (niraparib) is an oral, once-daily poly (ADP-ribose) polymerase (PARP) inhibitor with national Category 1 designation. It has been...